132
Participants
Start Date
February 18, 2025
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
AGN-151586
Intramuscular injection
OnabotulinumtoxinA
Intramuscular injection
Placebo
Intramuscular injection
SkinDC /ID# 270932, Arlington
Wilmington Dermatology Center /ID# 270828, Wilmington
Austin Institute for Clinical Research - Pflugerville /ID# 270834, Pflugerville
Investigate MD /ID# 270771, Scottsdale
Marcus Facial Plastic Surgery /ID# 270770, Redondo Beach
Eye Research Foundation /ID# 270827, Newport Beach
Skin Research Institute LLC /ID# 270831, Coral Gables
Skincare Physicians /ID# 271018, Chestnut Hill
Lead Sponsor
AbbVie
INDUSTRY